# Cancer and Blood Pressure Management, CARISMA Study

> **NCT04467021** · NA · ACTIVE_NOT_RECRUITING · sponsor: **ECOG-ACRIN Cancer Research Group** · enrollment: 61 (actual)

## Conditions studied

- Cardiovascular Disorder
- Chronic Kidney Disease
- Metastatic Renal Cell Carcinoma
- Metastatic Thyroid Gland Medullary Carcinoma
- Stage IV Renal Cell Cancer AJCC v8
- Stage IV Thyroid Gland Medullary Carcinoma AJCC v8
- Stage IVA Thyroid Gland Medullary Carcinoma AJCC v8
- Stage IVB Thyroid Gland Medullary Carcinoma AJCC v8
- Stage IVC Thyroid Gland Medullary Carcinoma AJCC v8

## Interventions

- **OTHER:** Best Practice
- **OTHER:** Blood Pressure Measurement
- **OTHER:** Clinical Management
- **OTHER:** Quality-of-Life Assessment
- **OTHER:** Questionnaire Administration

## Key facts

- **NCT ID:** NCT04467021
- **Lead sponsor:** ECOG-ACRIN Cancer Research Group
- **Sponsor class:** NETWORK
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2020-10-29
- **Primary completion:** 2026-08-31
- **Final completion:** 2026-08-31
- **Target enrollment:** 61 (ACTUAL)
- **Last updated:** 2026-05-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04467021

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04467021, "Cancer and Blood Pressure Management, CARISMA Study". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT04467021. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*